Skip to main content
. 2019 Sep 3;10:2095. doi: 10.3389/fimmu.2019.02095

Figure 8.

Figure 8

The role of Fpr2 in WKYMVm-induced immune resolution in scleroderma. (A,B) Wm-induced inhibition of systemic inflammation in scleroderma. The BLM-induced scleroderma mice model were treated with or without Wm for 3 weeks, and the serum levels of TNF-α (A) and INF-γ (B) in the mock-treated (PBS) and the scleroderma mice (BLM or BLM+Wm) were determined by ELISA assay. (C,D) The role of Fpr2 in Wm-induced suppression of systemic inflammation in scleroderma. The BLM-induced scleroderma model of wild type and Fpr2 KO mice were daily injected with or without Wm for 3 weeks, and the serum levels of TNF-α (C), and INF-γ (D) in the scleroderma mice were quantified by ELISA analysis. Data represent mean ± SD (n = 8 per group). *p < 0.05.